Clinical Trials

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06139419 2025-11-17

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

114 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06467617 2024-12-16

Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC

Phase 2 Recruiting

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02250326 2024-09-19

abound2L+

240 enrolled 23 charts

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06475755 2024-06-26

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

178 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05377658 2024-02-21

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Phase 2 Recruiting

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02716038 2023-12-12

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

39 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT02710396 2023-07-24

Genetic Predictors of Benefit to Pembrolizumab

Phase 2 Terminated

19 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT03345810 2023-06-15

DURATION

200 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04338620 2023-03-06

Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC

94 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02967133 2022-09-08

A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer

Phase 2 Terminated

7 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT04459611 2022-07-12

neoSCORE

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00979212 2022-06-15

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

71 enrolled 11 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04754815 2022-03-29

HFHS 21-01

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT02662634 2022-03-18

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT01620190 2021-07-16

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer

26 enrolled 12 charts

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04304248 2021-05-06

NeoTAP01

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04725448 2021-04-06

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

27 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

NCT02392507 2020-11-19

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

54 enrolled 16 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02730247 2020-11-19

Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

7 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT01702844 2020-10-08

Single Arm on the Tolerability of Weekly Nab-paclitaxel

42 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung

NCT00274443 2019-11-12

An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin

250 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT04153734 2019-11-06

Evolution

21 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02289456 2018-12-07

AboundPS2

40 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT02405910 2017-11-06

Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT02276560 2017-05-11

LCCC1407

Phase 2 Terminated

1 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT01494415 2015-12-15

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

21 enrolled